Article
rAAV-related therapy fully rescues myonuclear and myofilament function in X-linked myotubular myopathy.
Acta neuropathologica communications - 19 Oct 2020
Ross Jacob A, Tasfaout Hichem, Levy Yotam, Morgan Jennifer, Cowling Belinda S, Laporte Jocelyn, Zanoteli Edmar, Romero Norma B, Lowe Dawn A, Jungbluth Heinz, Lawlor Michael W, Mack David L, Ochala Julien
Abstract excerpt
X-linked myotubular myopathy (XLMTM) is a life-threatening skeletal muscle disease caused by mutations in the MTM1 gene. XLMTM fibres display a population of nuclei mispositioned in the centre. In the present study, we aimed to explore whether positioning and overall distribution of nuclei affects cellular organization and contractile function, thereby contributing to muscle weakness in this disease. We also...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
